Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Merck
Medtronic
Moodys
Colorcon
Baxter

Last Updated: August 8, 2022

Investigational Drug Information for D-Proline


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for D-Proline?

D-Proline is an investigational drug.

There have been 4 clinical trials for D-Proline. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2014.

The most common disease conditions in clinical trials are Polycythemia, Polycythemia Vera, and Leukemia, Myeloid. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, PharmaEssentia (Co-Sponsor for USA), and PharmaEssentia Corporation (for the U.S.).

There are two hundred US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for D-Proline
TitleSponsorPhase
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in RemissionAOP Orphan Pharmaceuticals AGPhase 3
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in RemissionDeutsche Krebshilfe e.V., Bonn (Germany)Phase 3
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in RemissionPhilipps University Marburg Medical CenterPhase 3

See all D-Proline clinical trials

Clinical Trial Summary for D-Proline

Top disease conditions for D-Proline
Top clinical trial sponsors for D-Proline

See all D-Proline clinical trials

US Patents for D-Proline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
D-Proline See Plans and Pricing Novel peptidyl carbamate inhibitors of the enzyme elastase University of Kentucky Research Foundation (Lexington, KY) See Plans and Pricing
D-Proline See Plans and Pricing Bis(benzylpyrrolidine) derivatives as dopamine agonists Syntex (U.S.A.) Inc. (Palo Alto, CA) See Plans and Pricing
D-Proline See Plans and Pricing Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure Syntex (U.S.A.) Inc. (Palo Alto, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Medtronic
Moodys
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.